Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
This approach holds promise for investigating the reduction of dosage of drugs with severe side effects and developing research compounds tailored to specific disease states
Bioavailability differences Injectable BPC-157 delivers essentially 100% of the administered dose to systemic circulation
The 60 mg vial is a compounded product
Four questions that should not be collapsed into one When peptide headlines circulate, separate these questions: Is FDA discussing the substance
TB-500 (Thymosin Beta-4) Not FDA-approved as a finished drug product, though clinical trials have used IV thymosin beta-4
US$ 29.03
US$ 25.86
US$ 20.66
US$ 23.75
